Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-05 @ 5:09 PM
Study NCT ID:
NCT00226668
Status:
WITHDRAWN
Last Update Posted:
2008-01-03
First Post:
2005-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Sponsor:
Celtic Pharma Development Services
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NTI 0302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Patrick Rossi, MD - Medical Monitor
Old Organization:
Celtic Pharma Development Services
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |